Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study. Miller AE, Macdonell R, Comi G, Freedman MS, Kappos L, Mäurer M, Olsson TP, Wolinsky JS, Bozzi S, Dive-Pouletty C, et al. J Neurol. 2014 Jun 28. Epub 2014 Jun 28. PMID: 24972678. Abstract CommentRecommendBookmarkWatch